Vaccine Inequity in the COVID-19 Crisis: Lessons to Leverage Global Health Law through Market-Shaping Policies.

This article critically examines the inequities in the access to COVID-19 vaccine and the lessons for global health law. Despite the rapid development and approval of COVID-19 vaccines, the rollout exposed severe systemic failures rooted in preexisting economic distortions and market inefficiencies. The article argues that addressing vaccine inequity requires more than improved distribution and solidarity, but effective reinvention of the global vaccine supply chain through evidence-based and meaningful market-shaping measures. It calls for a transformative approach to global health governance, emphasising the need for a comprehensive, human rights-compliant policy framework to correct structural problems in international markets, moving beyond superficial exhortations to equity.